Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Rifampicin + Isoniazid
- Therapeutic area
- Anti-infectives
- Drug class
- Antimycobacterials
- ATC
- J04AM
- Strength
- 300 mg + 150 mg
- Dosage form
- Tablet
- Pack
- 32’s
- Registration no.
- 005559
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What RIFINAH (Rifampicin + Isoniazid) is used for
Rifampicin + isoniazid is a combination of two antibiotics that kill the germ that causes tuberculosis (TB). Putting both medicines in one tablet means fewer tablets to take. It is part of the standard TB treatment used around the world. TB treatment is started and followed up by a TB doctor, TB nurse or TB programme team, and health workers or trained volunteers often support people until they finish.
- Treating TB (tuberculosis) disease, most often TB of the lungs. It is one part of a plan that uses several TB medicines together.
- In the later part of TB treatment, this two-medicine combination is often used on its own after the other TB medicines have stopped, as your TB team decides.
- Preventing TB in some people who have the TB germ in their body but are not ill (TB infection), such as children at risk. WHO says preventive treatment uses the same kinds of medicines for a shorter time than treatment for TB disease.
- Special dispersible tablets, mixed in water, are made for young children with TB.
Get medical help straight away if
- Get emergency help for signs of a severe allergic reaction: swelling of the face, lips, tongue or throat, wheezing, or trouble breathing or swallowing.
- Get emergency help for fits (seizures), sudden confusion, or trouble breathing.
- Stop and contact your TB team or a doctor straight away for signs of liver problems: yellow skin or eyes, dark or brown urine, pale stools, loss of appetite, feeling or being sick, unusual tiredness, or pain in the upper right side of the tummy. Liver damage can be serious and is more likely with alcohol.
- Get urgent help for a rash that blisters or peels, sores in the mouth, or a rash with fever.
Side effects, warnings and interactions for Rifampicin + Isoniazid
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Rifampicin + Isoniazid
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Rifampicin + Isoniazid is right for you and the dose.
- Tuberculosis (TB): short courses of isoniazid and rifampicin-type medicines for people with latent TB infection to stop it turning into TB disease
About RIFINAH 300 mg + 150 mg tablet
RIFINAH 300 mg + 150 mg tablet contains Rifampicin + Isoniazid 300 mg + 150 mg. It is registered with DRAP by Pacific Pharmaceutical Ltd (registration no. 005559). Its official price is PKR 1,280.92 for a pack of 32’s, about PKR 40.03 per tablet. This price has applied since 1 July 2024. RIFINAH is also available as 100 mg + 50 mg syrup, 150 mg + 75 mg tablet and 450 mg + 300 mg tablet. 5 other brands of Rifampicin + Isoniazid 300 mg + 150 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of RIFINAH
All 5 other brands of Rifampicin + Isoniazid 300 mg + 150 mg tablet in Pakistan
These 5 brands are alternatives (substitutes) to RIFINAH: each contains Rifampicin + Isoniazid 300 mg + 150 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is Rimazid (Cibex (Private) Limited) at PKR 8.48 per tablet; the highest is Rifapin at PKR 43.33. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Rimazid | Cibex (Private) Limited | 30's | PKR 254.53 | PKR 8.48 / tablet |
| Rimactal INH 300 | Global Pharmaceuticals (Pvt.) Ltd | 10 x 10's | PKR 1,564.43 | PKR 15.64 / tablet |
| Rimactal INH | Global Pharmaceuticals (Pvt.) Ltd | 3 x 10's | PKR 488.68 | PKR 16.29 / tablet |
| Pire2 | M/s. Genix Pharma (Pvt) Ltd | 10 x 10's | PKR 2,635.63 | PKR 26.36 / tablet |
| Rifapin | Schazoo Zaka (Pvt) Ltd | 10x10 | PKR 4,332.51 | PKR 43.33 / tablet |
How old is this price? It was fixed on 1 July 2024 and has not changed since — that is 2 years ago. It is still the price the Drug Regulatory Authority of Pakistan has notified, so it remains the official maximum, but it is not a figure from this month. Please check the current position before quoting it in an article, a tender or a purchase order.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for RIFINAH, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Pacific Pharmaceutical Ltd, Lahore
- DRAP registration
- 005559
- Phone
- +92 42 35975291-93
- info@pacificpharmaceuticals.com
- Website
- https://pacificpharmaceuticals.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (32’s). Current price PKR 1,280.92, effective 1 Jul 2024.
Cite this price history
MedInfoBase. RIFINAH 300 mg + 150 mg, 32’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/rifinah-300-mg-150-mg-005559-32s-pacific-pharmaceutical-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,280.92 | 2024-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 005559Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.